Links to Exploration step
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Molecular Analysis of the Interaction of the Snake Venom Rhodocytin with the Platelet Receptor CLEC-2</title><author><name sortKey="Watson, Aleksandra A" sort="Watson, Aleksandra A" uniqKey="Watson A" first="Aleksandra A." last="Watson">Aleksandra A. Watson</name><affiliation><nlm:aff id="af1-toxins-03-00991"> Department of Biochemistry, University of Cambridge/ 80 Tennis Court Road, Cambridge, CB2 1GA, UK; Email:<email>aaw36@cam.ac.uk</email></nlm:aff></affiliation></author><author><name sortKey="O Allaghan, Christopher A" sort="O Allaghan, Christopher A" uniqKey="O Allaghan C" first="Christopher A." last="O Allaghan">Christopher A. O Allaghan</name><affiliation><nlm:aff id="af2-toxins-03-00991"> Henry Wellcome Building for Molecular Physiology, University of Oxford/ Roosevelt Drive, Oxford, OX3 7BN, UK</nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">22069753</idno><idno type="pmc">3202865</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202865</idno><idno type="RBID">PMC:3202865</idno><idno type="doi">10.3390/toxins3080991</idno><date when="2011">2011</date><idno type="wicri:Area/Pmc/Corpus">004650</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">004650</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Molecular Analysis of the Interaction of the Snake Venom Rhodocytin with the Platelet Receptor CLEC-2</title><author><name sortKey="Watson, Aleksandra A" sort="Watson, Aleksandra A" uniqKey="Watson A" first="Aleksandra A." last="Watson">Aleksandra A. Watson</name><affiliation><nlm:aff id="af1-toxins-03-00991"> Department of Biochemistry, University of Cambridge/ 80 Tennis Court Road, Cambridge, CB2 1GA, UK; Email:<email>aaw36@cam.ac.uk</email></nlm:aff></affiliation></author><author><name sortKey="O Allaghan, Christopher A" sort="O Allaghan, Christopher A" uniqKey="O Allaghan C" first="Christopher A." last="O Allaghan">Christopher A. O Allaghan</name><affiliation><nlm:aff id="af2-toxins-03-00991"> Henry Wellcome Building for Molecular Physiology, University of Oxford/ Roosevelt Drive, Oxford, OX3 7BN, UK</nlm:aff></affiliation></author></analytic><series><title level="j">Toxins</title><idno type="eISSN">2072-6651</idno><imprint><date when="2011">2011</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p>The Malayan pit viper, <italic>Calloselasma rhodostoma</italic>, produces a potent venom toxin, rhodocytin (aggretin) which causes platelet aggregation. Rhodocytin is a ligand for the receptor CLEC-2 on the surface of platelets. The interaction of these two molecules initiates a signaling pathway which results in platelet activation and aggregation. We have previously solved the crystal structures of CLEC-2 and of rhodocytin, and have proposed models by which tetrameric rhodocytin may interact with either two monomers of CLEC-2, or with one or two copies of dimeric CLEC-2. In the current study we use a range of approaches to analyze the molecular interfaces and dynamics involved in the models of the interaction of rhodocytin with either one or two copies of dimeric CLEC-2, and their implications for clustering of CLEC-2 on the platelet surface. </p></div></front><back><div1 type="bibliography"><listBibl><biblStruct><analytic><author><name sortKey="Pirkle, H" uniqKey="Pirkle H">H. Pirkle</name></author><author><name sortKey="Markland, F S" uniqKey="Markland F">F.S. Markland</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Clemetson, K J" uniqKey="Clemetson K">K.J. Clemetson</name></author><author><name sortKey="Lu, Q" uniqKey="Lu Q">Q. Lu</name></author><author><name sortKey="Clemetson, J M" uniqKey="Clemetson J">J.M. Clemetson</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Clemetson, K J" uniqKey="Clemetson K">K.J. Clemetson</name></author><author><name sortKey="Lu, Q" uniqKey="Lu Q">Q. Lu</name></author><author><name sortKey="Clemetson, J M" uniqKey="Clemetson J">J.M. Clemetson</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ruggeri, Z M" uniqKey="Ruggeri Z">Z.M. Ruggeri</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Lusis, A J" uniqKey="Lusis A">A.J. Lusis</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ho, M" uniqKey="Ho M">M. Ho</name></author><author><name sortKey="Warrell, D A" uniqKey="Warrell D">D.A. Warrell</name></author><author><name sortKey="Looareesuwan, S" uniqKey="Looareesuwan S">S. Looareesuwan</name></author><author><name sortKey="Phillips, R E" uniqKey="Phillips R">R.E. Phillips</name></author><author><name sortKey="Chanthavanich, P" uniqKey="Chanthavanich P">P. Chanthavanich</name></author><author><name sortKey="Karbwang, J" uniqKey="Karbwang J">J. Karbwang</name></author><author><name sortKey="Supanaranond, W" uniqKey="Supanaranond W">W. Supanaranond</name></author><author><name sortKey="Viravan, C" uniqKey="Viravan C">C. Viravan</name></author><author><name sortKey="Hutton, R A" uniqKey="Hutton R">R.A. Hutton</name></author><author><name sortKey="Vejcho, S" uniqKey="Vejcho S">S. Vejcho</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Huang, T F" uniqKey="Huang T">T.F. Huang</name></author><author><name sortKey="Liu, C Z" uniqKey="Liu C">C.Z. Liu</name></author><author><name sortKey="Yang, S H" uniqKey="Yang S">S.H. Yang</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Shin, Y" uniqKey="Shin Y">Y. Shin</name></author><author><name sortKey="Morita, T" uniqKey="Morita T">T. Morita</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Chung, C H" uniqKey="Chung C">C.H. Chung</name></author><author><name sortKey="Au, L C" uniqKey="Au L">L.C. Au</name></author><author><name sortKey="Huang, T F" uniqKey="Huang T">T.F. Huang</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Suzuki Inoue, K" uniqKey="Suzuki Inoue K">K. Suzuki-Inoue</name></author><author><name sortKey="Fuller, G L" uniqKey="Fuller G">G.L. Fuller</name></author><author><name sortKey="Garcia, A" uniqKey="Garcia A">A. Garcia</name></author><author><name sortKey="Eble, J A" uniqKey="Eble J">J.A. Eble</name></author><author><name sortKey="Pohlmann, S" uniqKey="Pohlmann S">S. Pohlmann</name></author><author><name sortKey="Inoue, O" uniqKey="Inoue O">O. Inoue</name></author><author><name sortKey="Gartner, T K" uniqKey="Gartner T">T.K. Gartner</name></author><author><name sortKey="Hughan, S C" uniqKey="Hughan S">S.C. Hughan</name></author><author><name sortKey="Pearce, A C" uniqKey="Pearce A">A.C. Pearce</name></author><author><name sortKey="Laing, G D" uniqKey="Laing G">G.D. Laing</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Fuller, G L" uniqKey="Fuller G">G.L. Fuller</name></author><author><name sortKey="Williams, J A" uniqKey="Williams J">J.A. Williams</name></author><author><name sortKey="Tomlinson, M G" uniqKey="Tomlinson M">M.G. Tomlinson</name></author><author><name sortKey="Eble, J A" uniqKey="Eble J">J.A. Eble</name></author><author><name sortKey="Hanna, S L" uniqKey="Hanna S">S.L. Hanna</name></author><author><name sortKey="Pohlmann, S" uniqKey="Pohlmann S">S. Pohlmann</name></author><author><name sortKey="Suzuki Inoue, K" uniqKey="Suzuki Inoue K">K. Suzuki-Inoue</name></author><author><name sortKey="Ozaki, Y" uniqKey="Ozaki Y">Y. Ozaki</name></author><author><name sortKey="Watson, S P" uniqKey="Watson S">S.P. Watson</name></author><author><name sortKey="Pearce, A C" uniqKey="Pearce A">A.C. Pearce</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="O Allaghan, C A" uniqKey="O Allaghan C">C.A. O’Callaghan</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="O Allaghan, C A" uniqKey="O Allaghan C">C.A. O’Callaghan</name></author><author><name sortKey="Tormo, J" uniqKey="Tormo J">J. Tormo</name></author><author><name sortKey="Willcox, B E" uniqKey="Willcox B">B.E. Willcox</name></author><author><name sortKey="Braud, V M" uniqKey="Braud V">V.M. Braud</name></author><author><name sortKey="Jakobsen, B K" uniqKey="Jakobsen B">B.K. Jakobsen</name></author><author><name sortKey="Stuart, D I" uniqKey="Stuart D">D.I. Stuart</name></author><author><name sortKey="Mcmichael, A J" uniqKey="Mcmichael A">A.J. McMichael</name></author><author><name sortKey="Bell, J I" uniqKey="Bell J">J.I. Bell</name></author><author><name sortKey="Jones, E Y" uniqKey="Jones E">E.Y. Jones</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Braud, V" uniqKey="Braud V">V. Braud</name></author><author><name sortKey="Allan, D S J" uniqKey="Allan D">D.S.J. Allan</name></author><author><name sortKey="O Allaghan, C A" uniqKey="O Allaghan C">C.A. O’Callaghan</name></author><author><name sortKey="Ogg, G S" uniqKey="Ogg G">G.S. Ogg</name></author><author><name sortKey="Lazetic, S" uniqKey="Lazetic S">S. Lazetic</name></author><author><name sortKey="Young, N T" uniqKey="Young N">N.T. Young</name></author><author><name sortKey="Bell, J I" uniqKey="Bell J">J.I. Bell</name></author><author><name sortKey="Phillips, J H" uniqKey="Phillips J">J.H. Phillips</name></author><author><name sortKey="Lanier, L L" uniqKey="Lanier L">L.L. Lanier</name></author><author><name sortKey="Mcmichael, A J" uniqKey="Mcmichael A">A.J. McMichael</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="O Allaghan, C A" uniqKey="O Allaghan C">C.A. O’Callaghan</name></author><author><name sortKey="Cerwenka, A" uniqKey="Cerwenka A">A. Cerwenka</name></author><author><name sortKey="Willcox, B E" uniqKey="Willcox B">B.E. Willcox</name></author><author><name sortKey="Lanier, L L" uniqKey="Lanier L">L.L. Lanier</name></author><author><name sortKey="Bjorkman, P J" uniqKey="Bjorkman P">P.J. Bjorkman</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Christou, C M" uniqKey="Christou C">C.M. Christou</name></author><author><name sortKey="Pearce, A C" uniqKey="Pearce A">A.C. Pearce</name></author><author><name sortKey="Watson, A A" uniqKey="Watson A">A.A. Watson</name></author><author><name sortKey="Mistry, A R" uniqKey="Mistry A">A.R. Mistry</name></author><author><name sortKey="Pollitt, A Y" uniqKey="Pollitt A">A.Y. Pollitt</name></author><author><name sortKey="Fenton May, A E" uniqKey="Fenton May A">A.E. Fenton-May</name></author><author><name sortKey="Johnson, L A" uniqKey="Johnson L">L.A. Johnson</name></author><author><name sortKey="Jackson, D G" uniqKey="Jackson D">D.G. Jackson</name></author><author><name sortKey="Watson, S P" uniqKey="Watson S">S.P. Watson</name></author><author><name sortKey="O Allaghan, C A" uniqKey="O Allaghan C">C.A. O’Callaghan</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="O Allaghan, C A" uniqKey="O Allaghan C">C.A. O’Callaghan</name></author><author><name sortKey="Jones, E Y" uniqKey="Jones E">E.Y. Jones</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Cueni, L N" uniqKey="Cueni L">L.N. Cueni</name></author><author><name sortKey="Chen, L" uniqKey="Chen L">L. Chen</name></author><author><name sortKey="Zhang, H" uniqKey="Zhang H">H. Zhang</name></author><author><name sortKey="Marino, D" uniqKey="Marino D">D. Marino</name></author><author><name sortKey="Huggenberger, R" uniqKey="Huggenberger R">R. Huggenberger</name></author><author><name sortKey="Alitalo, A" uniqKey="Alitalo A">A. Alitalo</name></author><author><name sortKey="Bianchi, R" uniqKey="Bianchi R">R. Bianchi</name></author><author><name sortKey="Detmar, M" uniqKey="Detmar M">M. Detmar</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Suzuki Inoue, K" uniqKey="Suzuki Inoue K">K. Suzuki-Inoue</name></author><author><name sortKey="Kato, Y" uniqKey="Kato Y">Y. Kato</name></author><author><name sortKey="Inoue, O" uniqKey="Inoue O">O. Inoue</name></author><author><name sortKey="Kaneko, M K" uniqKey="Kaneko M">M.K. Kaneko</name></author><author><name sortKey="Mishima, K" uniqKey="Mishima K">K. Mishima</name></author><author><name sortKey="Yatomi, Y" uniqKey="Yatomi Y">Y. Yatomi</name></author><author><name sortKey="Narimatsu, H" uniqKey="Narimatsu H">H. Narimatsu</name></author><author><name sortKey="Ozaki, Y" uniqKey="Ozaki Y">Y. Ozaki</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Martin Villar, E" uniqKey="Martin Villar E">E. Martin-Villar</name></author><author><name sortKey="Scholl, F G" uniqKey="Scholl F">F.G. Scholl</name></author><author><name sortKey="Gamallo, C" uniqKey="Gamallo C">C. Gamallo</name></author><author><name sortKey="Yurrita, M M" uniqKey="Yurrita M">M.M. Yurrita</name></author><author><name sortKey="Munoz Guerra, M" uniqKey="Munoz Guerra M">M. Munoz-Guerra</name></author><author><name sortKey="Cruces, J" uniqKey="Cruces J">J. Cruces</name></author><author><name sortKey="Quintanilla, M" uniqKey="Quintanilla M">M. Quintanilla</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Uhrin, P" uniqKey="Uhrin P">P. Uhrin</name></author><author><name sortKey="Zaujec, J" uniqKey="Zaujec J">J. Zaujec</name></author><author><name sortKey="Breuss, J M" uniqKey="Breuss J">J.M. Breuss</name></author><author><name sortKey="Olcaydu, D" uniqKey="Olcaydu D">D. Olcaydu</name></author><author><name sortKey="Chrenek, P" uniqKey="Chrenek P">P. Chrenek</name></author><author><name sortKey="Stockinger, H" uniqKey="Stockinger H">H. Stockinger</name></author><author><name sortKey="Fuertbauer, E" uniqKey="Fuertbauer E">E. Fuertbauer</name></author><author><name sortKey="Moser, M" uniqKey="Moser M">M. Moser</name></author><author><name sortKey="Haiko, P" uniqKey="Haiko P">P. Haiko</name></author><author><name sortKey="Fassler, R" uniqKey="Fassler R">R. Fassler</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Schacht, V" uniqKey="Schacht V">V. Schacht</name></author><author><name sortKey="Ramirez, M I" uniqKey="Ramirez M">M.I. Ramirez</name></author><author><name sortKey="Hong, Y K" uniqKey="Hong Y">Y.K. Hong</name></author><author><name sortKey="Hirakawa, S" uniqKey="Hirakawa S">S. Hirakawa</name></author><author><name sortKey="Feng, D" uniqKey="Feng D">D. Feng</name></author><author><name sortKey="Harvey, N" uniqKey="Harvey N">N. Harvey</name></author><author><name sortKey="Williams, M" uniqKey="Williams M">M. Williams</name></author><author><name sortKey="Dvorak, A M" uniqKey="Dvorak A">A.M. Dvorak</name></author><author><name sortKey="Dvorak, H F" uniqKey="Dvorak H">H.F. Dvorak</name></author><author><name sortKey="Oliver, G" uniqKey="Oliver G">G. Oliver</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Mahtab, E A" uniqKey="Mahtab E">E.A. Mahtab</name></author><author><name sortKey="Vicente Steijn, R" uniqKey="Vicente Steijn R">R. Vicente-Steijn</name></author><author><name sortKey="Hahurij, N D" uniqKey="Hahurij N">N.D. Hahurij</name></author><author><name sortKey="Jongbloed, M R" uniqKey="Jongbloed M">M.R. Jongbloed</name></author><author><name sortKey="Wisse, L J" uniqKey="Wisse L">L.J. Wisse</name></author><author><name sortKey="Deruiter, M C" uniqKey="Deruiter M">M.C. DeRuiter</name></author><author><name sortKey="Uhrin, P" uniqKey="Uhrin P">P. Uhrin</name></author><author><name sortKey="Zaujec, J" uniqKey="Zaujec J">J. Zaujec</name></author><author><name sortKey="Binder, B R" uniqKey="Binder B">B.R. Binder</name></author><author><name sortKey="Schalij, M J" uniqKey="Schalij M">M.J. Schalij</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Douglas, Y L" uniqKey="Douglas Y">Y.L. Douglas</name></author><author><name sortKey="Mahtab, E A" uniqKey="Mahtab E">E.A. Mahtab</name></author><author><name sortKey="Jongbloed, M R" uniqKey="Jongbloed M">M.R. Jongbloed</name></author><author><name sortKey="Uhrin, P" uniqKey="Uhrin P">P. Uhrin</name></author><author><name sortKey="Zaujec, J" uniqKey="Zaujec J">J. Zaujec</name></author><author><name sortKey="Binder, B R" uniqKey="Binder B">B.R. Binder</name></author><author><name sortKey="Schalij, M J" uniqKey="Schalij M">M.J. Schalij</name></author><author><name sortKey="Poelmann, R E" uniqKey="Poelmann R">R.E. Poelmann</name></author><author><name sortKey="Deruiter, M C" uniqKey="Deruiter M">M.C. Deruiter</name></author><author><name sortKey="Gittenberger De Groot, A C" uniqKey="Gittenberger De Groot A">A.C. Gittenberger-de Groot</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hughes, C E" uniqKey="Hughes C">C.E. Hughes</name></author><author><name sortKey="Navarro Nu Ez, L" uniqKey="Navarro Nu Ez L">L. Navarro-Núñez</name></author><author><name sortKey="Finney, B A" uniqKey="Finney B">B.A. Finney</name></author><author><name sortKey="Mourao Sa, D" uniqKey="Mourao Sa D">D. Mourão-Sá</name></author><author><name sortKey="Pollitt, A Y" uniqKey="Pollitt A">A.Y. Pollitt</name></author><author><name sortKey="Watson, S P" uniqKey="Watson S">S.P. Watson</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Tang, T" uniqKey="Tang T">T. Tang</name></author><author><name sortKey="Li, L" uniqKey="Li L">L. Li</name></author><author><name sortKey="Tang, J" uniqKey="Tang J">J. Tang</name></author><author><name sortKey="Li, Y" uniqKey="Li Y">Y. Li</name></author><author><name sortKey="Lin, W Y" uniqKey="Lin W">W.Y. Lin</name></author><author><name sortKey="Martin, F" uniqKey="Martin F">F. Martin</name></author><author><name sortKey="Grant, D" uniqKey="Grant D">D. Grant</name></author><author><name sortKey="Solloway, M" uniqKey="Solloway M">M. Solloway</name></author><author><name sortKey="Parker, L" uniqKey="Parker L">L. Parker</name></author><author><name sortKey="Ye, W" uniqKey="Ye W">W. Ye</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Bertozzi, C C" uniqKey="Bertozzi C">C.C. Bertozzi</name></author><author><name sortKey="Schmaier, A A" uniqKey="Schmaier A">A.A. Schmaier</name></author><author><name sortKey="Mericko, P" uniqKey="Mericko P">P. Mericko</name></author><author><name sortKey="Hess, P R" uniqKey="Hess P">P.R. Hess</name></author><author><name sortKey="Zou, Z" uniqKey="Zou Z">Z. Zou</name></author><author><name sortKey="Chen, M" uniqKey="Chen M">M. Chen</name></author><author><name sortKey="Chen, C Y" uniqKey="Chen C">C.Y. Chen</name></author><author><name sortKey="Xu, B" uniqKey="Xu B">B. Xu</name></author><author><name sortKey="Lu, M M" uniqKey="Lu M">M.M. Lu</name></author><author><name sortKey="Zhou, D" uniqKey="Zhou D">D. Zhou</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Suzuki Inoue, K" uniqKey="Suzuki Inoue K">K. Suzuki-Inoue</name></author><author><name sortKey="Inoue, O" uniqKey="Inoue O">O. Inoue</name></author><author><name sortKey="Ding, G" uniqKey="Ding G">G. Ding</name></author><author><name sortKey="Nishimura, S" uniqKey="Nishimura S">S. Nishimura</name></author><author><name sortKey="Hokamura, K" uniqKey="Hokamura K">K. Hokamura</name></author><author><name sortKey="Eto, K" uniqKey="Eto K">K. Eto</name></author><author><name sortKey="Kashiwagi, H" uniqKey="Kashiwagi H">H. Kashiwagi</name></author><author><name sortKey="Tomiyama, Y" uniqKey="Tomiyama Y">Y. Tomiyama</name></author><author><name sortKey="Yatomi, Y" uniqKey="Yatomi Y">Y. Yatomi</name></author><author><name sortKey="Umemura, K" uniqKey="Umemura K">K. Umemura</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Chippaux, J P" uniqKey="Chippaux J">J.P. Chippaux</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Watson, A A" uniqKey="Watson A">A.A. Watson</name></author><author><name sortKey="Brown, J" uniqKey="Brown J">J. Brown</name></author><author><name sortKey="Harlos, K" uniqKey="Harlos K">K. Harlos</name></author><author><name sortKey="Eble, J A" uniqKey="Eble J">J.A. Eble</name></author><author><name sortKey="Walter, T S" uniqKey="Walter T">T.S. Walter</name></author><author><name sortKey="O Allaghan, C A" uniqKey="O Allaghan C">C.A. O’Callaghan</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Watson, A A" uniqKey="Watson A">A.A. Watson</name></author><author><name sortKey="O Allaghan, C A" uniqKey="O Allaghan C">C.A. O’Callaghan</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Watson, A A" uniqKey="Watson A">A.A. Watson</name></author><author><name sortKey="Christou, C M" uniqKey="Christou C">C.M. Christou</name></author><author><name sortKey="James, J R" uniqKey="James J">J.R. James</name></author><author><name sortKey="Fenton May, A E" uniqKey="Fenton May A">A.E. Fenton-May</name></author><author><name sortKey="Moncayo, G E" uniqKey="Moncayo G">G.E. Moncayo</name></author><author><name sortKey="Mistry, A R" uniqKey="Mistry A">A.R. Mistry</name></author><author><name sortKey="Davis, S J" uniqKey="Davis S">S.J. Davis</name></author><author><name sortKey="Gilbert, R J" uniqKey="Gilbert R">R.J. Gilbert</name></author><author><name sortKey="Chakera, A" uniqKey="Chakera A">A. Chakera</name></author><author><name sortKey="O Allaghan, C A" uniqKey="O Allaghan C">C.A. O’Callaghan</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Watson, A A" uniqKey="Watson A">A.A. Watson</name></author><author><name sortKey="Eble, J A" uniqKey="Eble J">J.A. Eble</name></author><author><name sortKey="O Allaghan, C A" uniqKey="O Allaghan C">C.A. O’Callaghan</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hughes, C E" uniqKey="Hughes C">C.E. Hughes</name></author><author><name sortKey="Pollitt, A Y" uniqKey="Pollitt A">A.Y. Pollitt</name></author><author><name sortKey="Mori, J" uniqKey="Mori J">J. Mori</name></author><author><name sortKey="Eble, J A" uniqKey="Eble J">J.A. Eble</name></author><author><name sortKey="Tomlinson, M G" uniqKey="Tomlinson M">M.G. Tomlinson</name></author><author><name sortKey="Hartwig, J H" uniqKey="Hartwig J">J.H. Hartwig</name></author><author><name sortKey="O Allaghan, C A" uniqKey="O Allaghan C">C.A. O’Callaghan</name></author><author><name sortKey="Futterer, K" uniqKey="Futterer K">K. Futterer</name></author><author><name sortKey="Watson, S P" uniqKey="Watson S">S.P. Watson</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Krissinel, E" uniqKey="Krissinel E">E. Krissinel</name></author><author><name sortKey="Henrick, K" uniqKey="Henrick K">K. Henrick</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Barrett, C P" uniqKey="Barrett C">C.P. Barrett</name></author><author><name sortKey="Hall, B A" uniqKey="Hall B">B.A. Hall</name></author><author><name sortKey="Noble, M E" uniqKey="Noble M">M.E. Noble</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="De Groot, B L" uniqKey="De Groot B">B.L. De Groot</name></author><author><name sortKey="Van Aalten, D M" uniqKey="Van Aalten D">D.M. van Aalten</name></author><author><name sortKey="Scheek, R M" uniqKey="Scheek R">R.M. Scheek</name></author><author><name sortKey="Amadei, A" uniqKey="Amadei A">A. Amadei</name></author><author><name sortKey="Vriend, G" uniqKey="Vriend G">G. Vriend</name></author><author><name sortKey="Berendsen, H J" uniqKey="Berendsen H">H.J. Berendsen</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Humphrey, W" uniqKey="Humphrey W">W. Humphrey</name></author><author><name sortKey="Dalke, A" uniqKey="Dalke A">A. Dalke</name></author><author><name sortKey="Schulten, K" uniqKey="Schulten K">K. Schulten</name></author></analytic></biblStruct></listBibl></div1></back></TEI><pmc article-type="research-article"><pmc-dir>properties open_access</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Toxins (Basel)</journal-id><journal-id journal-id-type="publisher-id">toxins</journal-id><journal-title-group><journal-title>Toxins</journal-title></journal-title-group><issn pub-type="epub">2072-6651</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">22069753</article-id><article-id pub-id-type="pmc">3202865</article-id><article-id pub-id-type="doi">10.3390/toxins3080991</article-id><article-id pub-id-type="publisher-id">toxins-03-00991</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Molecular Analysis of the Interaction of the Snake Venom Rhodocytin with the Platelet Receptor CLEC-2</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Watson</surname><given-names>Aleksandra A.</given-names></name><xref ref-type="aff" rid="af1-toxins-03-00991">1</xref></contrib><contrib contrib-type="author"><name><surname>O’Callaghan</surname><given-names>Christopher A.</given-names></name><xref ref-type="aff" rid="af2-toxins-03-00991">2</xref><xref rid="c1-toxins-03-00991" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-toxins-03-00991"><label>1</label> Department of Biochemistry, University of Cambridge/ 80 Tennis Court Road, Cambridge, CB2 1GA, UK; Email:<email>aaw36@cam.ac.uk</email></aff><aff id="af2-toxins-03-00991"><label>2</label> Henry Wellcome Building for Molecular Physiology, University of Oxford/ Roosevelt Drive, Oxford, OX3 7BN, UK</aff><author-notes><corresp id="c1-toxins-03-00991"><label>*</label> Author to whom correspondence should be addressed; Email: <email>chris.ocallaghan@ndm.ox.ac.uk</email>; Tel.: +44-1865-287789; Fax: +44-1865-287787.</corresp></author-notes><pub-date pub-type="epub"><day>10</day><month>8</month><year>2011</year></pub-date><pub-date pub-type="collection"><month>8</month><year>2011</year></pub-date><volume>3</volume><issue>8</issue><fpage>991</fpage><lpage>1003</lpage><history><date date-type="received"><day>06</day><month>7</month><year>2011</year></date><date date-type="rev-recd"><day>21</day><month>7</month><year>2011</year></date><date date-type="accepted"><day>08</day><month>8</month><year>2011</year></date></history><permissions><copyright-statement>© 2011 by the authors; licensee MDPI, Basel, Switzerland.</copyright-statement><copyright-year>2011</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p><pmc-comment>CREATIVE COMMONS</pmc-comment>This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">http://creativecommons.org/licenses/by/3.0/</ext-link>).</license-p></license></permissions><abstract><p>The Malayan pit viper, <italic>Calloselasma rhodostoma</italic>, produces a potent venom toxin, rhodocytin (aggretin) which causes platelet aggregation. Rhodocytin is a ligand for the receptor CLEC-2 on the surface of platelets. The interaction of these two molecules initiates a signaling pathway which results in platelet activation and aggregation. We have previously solved the crystal structures of CLEC-2 and of rhodocytin, and have proposed models by which tetrameric rhodocytin may interact with either two monomers of CLEC-2, or with one or two copies of dimeric CLEC-2. In the current study we use a range of approaches to analyze the molecular interfaces and dynamics involved in the models of the interaction of rhodocytin with either one or two copies of dimeric CLEC-2, and their implications for clustering of CLEC-2 on the platelet surface. </p></abstract><kwd-group><kwd>rhodocytin</kwd><kwd>CLEC-2</kwd><kwd>platelets</kwd><kwd>thrombosis</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>1. Introduction</title><p>A range of snake toxins have evolved to influence blood clotting and platelet aggregation [<xref ref-type="bibr" rid="B1-toxins-03-00991">1</xref>]. Various C-type lectin-like proteins influence platelet aggregation through interactions with receptors on the surface of platelets; a number of these venom proteins are heterodimeric [<xref ref-type="bibr" rid="B2-toxins-03-00991">2</xref>,<xref ref-type="bibr" rid="B3-toxins-03-00991">3</xref>]. Platelet activation and aggregation can be triggered by various well defined receptors on the surface of platelets. Under typical physiological conditions, GPIb-V-IX and αIIbβ3 integrin interact with von Willebrand factor when the latter has become attached to extracellular collagen. Collagen itself interacts with the immunoglobulin superfamily receptor GPVI and the integrin α2β1 [<xref ref-type="bibr" rid="B4-toxins-03-00991">4</xref>,<xref ref-type="bibr" rid="B5-toxins-03-00991">5</xref>]. There is great biomedical interest in the discovery of novel platelet-activating receptors and in this respect the identification of the targets on platelets for snake venom proteins has been an important objective.</p><p>The Malayan pit viper <italic>Calloselasma rhodostoma</italic> is a major cause of snakebite morbidity in large parts of Southeast Asia and effects on platelet function are key consequences of envenomation [<xref ref-type="bibr" rid="B6-toxins-03-00991">6</xref>]. The pit viper produces a venom protein, rhodocytin (aggretin) which was purified and shown to cause powerful platelet activation and aggregation [<xref ref-type="bibr" rid="B7-toxins-03-00991">7</xref>,<xref ref-type="bibr" rid="B8-toxins-03-00991">8</xref>]. The molecular cloning and sequence analysis of rhodocytin demonstrated that the two subunits, designated alpha and beta, each have characteristics of the C-type lectin-like family [<xref ref-type="bibr" rid="B9-toxins-03-00991">9</xref>]. Rhodocytin has been shown to be a ligand for CLEC-2, a recently identified receptor on the surface of platelets [<xref ref-type="bibr" rid="B10-toxins-03-00991">10</xref>]. Binding of rhodocytin to CLEC-2 triggers a potent platelet signaling pathway [<xref ref-type="bibr" rid="B10-toxins-03-00991">10</xref>,<xref ref-type="bibr" rid="B11-toxins-03-00991">11</xref>]. CLEC-2 contains a single YXXL motif in its cytoplasmic tail. Rhodocytin binding leads to tyrosine phosphorylation in this cytoplasmic tail of CLEC-2, which promotes the binding of spleen tyrosine kinase (Syk), subsequent activation of PLCγ2 and platelet activation and aggregation [<xref ref-type="bibr" rid="B10-toxins-03-00991">10</xref>]. CLEC-2 is encoded in a genomic cluster with related C-type lectin-like molecules, some of which have immunological roles, as exemplified by NKG2D [<xref ref-type="bibr" rid="B12-toxins-03-00991">12</xref>,<xref ref-type="bibr" rid="B13-toxins-03-00991">13</xref>,<xref ref-type="bibr" rid="B14-toxins-03-00991">14</xref>,<xref ref-type="bibr" rid="B15-toxins-03-00991">15</xref>,<xref ref-type="bibr" rid="B16-toxins-03-00991">16</xref>,<xref ref-type="bibr" rid="B17-toxins-03-00991">17</xref>]. CLEC-2 was first identified as a receptor on platelets for rhodocytin and may also play a role in lymphatic development [<xref ref-type="bibr" rid="B10-toxins-03-00991">10</xref>,<xref ref-type="bibr" rid="B18-toxins-03-00991">18</xref>]. We and others have shown that podoplanin is an endogenous ligand for CLEC-2 [<xref ref-type="bibr" rid="B16-toxins-03-00991">16</xref>,<xref ref-type="bibr" rid="B19-toxins-03-00991">19</xref>]. Podoplanin is expressed on the luminal aspect of lymphatic endothelial cells and in a range of tissues including kidney, heart, lung and many tumours [<xref ref-type="bibr" rid="B20-toxins-03-00991">20</xref>]. The biological importance of CLEC-2 and podoplanin is indicated by observations that genetic knockouts of either molecule are lethal during embryonic development [<xref ref-type="bibr" rid="B21-toxins-03-00991">21</xref>,<xref ref-type="bibr" rid="B22-toxins-03-00991">22</xref>,<xref ref-type="bibr" rid="B23-toxins-03-00991">23</xref>,<xref ref-type="bibr" rid="B24-toxins-03-00991">24</xref>,<xref ref-type="bibr" rid="B25-toxins-03-00991">25</xref>,<xref ref-type="bibr" rid="B26-toxins-03-00991">26</xref>,<xref ref-type="bibr" rid="B27-toxins-03-00991">27</xref>,<xref ref-type="bibr" rid="B28-toxins-03-00991">28</xref>].</p><p>The mechanism whereby rhodocytin triggers platelet aggregation is of great interest because a detailed knowledge of CLEC-2-mediated platelet activation could be of value in understanding and preventing platelet aggregation in thrombotic coronary and cerebral vascular disease, which are major causes of disability and death worldwide. Furthermore, there is a strong need to understand the rhodocytin-CLEC-2 interaction in its own right as snake envenomation affects over 2.5 million humans per year, causing more than 100,000 deaths [<xref ref-type="bibr" rid="B29-toxins-03-00991">29</xref>]. We have solved the structure of the C-type lectin-like domain of CLEC-2 and have used mutagenesis to characterise the interaction with rhodocytin [<xref ref-type="bibr" rid="B30-toxins-03-00991">30</xref>,<xref ref-type="bibr" rid="B31-toxins-03-00991">31</xref>]. The binding affinity of CLEC-2 with rhodocytin and podoplanin has been measured using surface plasmon resonance (Biacore technology) [<xref ref-type="bibr" rid="B16-toxins-03-00991">16</xref>,<xref ref-type="bibr" rid="B30-toxins-03-00991">30</xref>,<xref ref-type="bibr" rid="B32-toxins-03-00991">32</xref>]. We found the affinity of the interaction of rhodocytin with monomeric CLEC-2 to be 1.01 ± 0.20 μM, as compared with 24.5 ± 3.7 μM and 4.1 ± 0.2 μM for the interactions of podoplanin with monomeric and dimeric CLEC-2 respectively [<xref ref-type="bibr" rid="B16-toxins-03-00991">16</xref>,<xref ref-type="bibr" rid="B30-toxins-03-00991">30</xref>,<xref ref-type="bibr" rid="B32-toxins-03-00991">32</xref>].</p><p>To further explore the association between CLEC-2 and rhodocytin, we have also solved the crystal structure of rhodocytin, and discovered that it assembles as a non-disulfide linked (αβ)<sub>2</sub> tetramer [<xref ref-type="bibr" rid="B33-toxins-03-00991">33</xref>]. Rhodocytin is the first snake venom or other C-type lectin-like protein reported to adopt this configuration. We proposed that the rhodocytin tetramer might induce clustering of CLEC-2 molecules on the platelet surface and that this could play a key role in triggering signaling to platelet activation. We have previously generated three models of the rhodocytin-CLEC-2 interaction, whereby tetrameric rhodocytin may promote clustering of CLEC-2 by interacting with two copies of monomeric CLEC-2, one copy of dimeric CLEC-2, or two copies of dimeric CLEC-2. We have since used a range of cellular, biochemical and biophysical techniques to demonstrate that CLEC-2 exists as a non-disulfide-linked homodimer [<xref ref-type="bibr" rid="B32-toxins-03-00991">32</xref>]. Although Syk generally interacts with two YXXL motifs on a single polypeptide chain, there is evidence to indicate that it can interact with two YXXL motifs, each from a different CLEC-2 chain, consistent with CLEC-2 functioning in a dimeric manner in its interaction with Syk [<xref ref-type="bibr" rid="B34-toxins-03-00991">34</xref>]. These observations preclude the first of our original models of the rhodocytin-CLEC-2 interaction, wherein two copies of monomeric CLEC-2 bind to tetrameric rhodocytin. In the current study, we analyse and discuss the interactions involved in the two other models of the interaction, where rhodocytin may bind either one or two copies of dimeric CLEC-2, and discuss the implications for clustering of CLEC-2 on the platelet surface.</p></sec><sec><title>2. Materials and Methods</title><sec><title>2.1. Protein Interfaces, Surfaces and Assemblies</title><p>Algorithms implemented by PISA (Protein interfaces, surfaces and assemblies version 1.2) were used to explore the macromolecular protein interfaces of the model complexes of rhodocytin plus either one, or two copies of model dimeric CLEC-2 [<xref ref-type="bibr" rid="B35-toxins-03-00991">35</xref>]. These models were generated as previously reported [<xref ref-type="bibr" rid="B33-toxins-03-00991">33</xref>]. These calculations included the structural and chemical properties of macromolecular surfaces and interfaces, the accessible/buried surface area, the free energy of dissociation, and the presence or absence of salt bridges and disulfide bonds. The protein database archive (PDB) was searched for particular interfaces formed by structural homologs, and the PISA database was explored to compare results for multimeric state, symmetry number, space group, accessible/buried surface area, free energy of dissociation, presence/absence of salt bridges and disulfide bonds, homomeric type, and ligands. Structures, interfaces and assemblies were visualised for analysis using Rastop and Jmol (an open-source Java viewer for chemical structures in 3D. <uri xlink:type="simple" xlink:href="http://www.jmol.org/">http://www.jmol.org/</uri>).</p></sec><sec><title>2.2. Molecular Dynamics</title><p>The potential modes of motion of the different models of the rhodocytin-CLEC-2 complex were examined and analysed using the Dynamite package [<xref ref-type="bibr" rid="B36-toxins-03-00991">36</xref>]. From the input three dimensional structure, an ensemble of structures was generated, and subsequently analysed to predict which elements move together and the relevant vectors of these motions. The ensemble was generated using Concoord, and the analysis was performed using Gromacs. In essence, Concoord is used to identify all interatomic interactions in the structure which is input [<xref ref-type="bibr" rid="B37-toxins-03-00991">37</xref>]. The likely strength of these interactions is analysed and so the potential freedom of the interacting species is modeled to within appropriate bounds. Following this, new variant structures are established that fulfill the limitations of these modeled bounds. These dynamic analyses were represented graphically using Visual Molecular Dynamics (VMD) [<xref ref-type="bibr" rid="B38-toxins-03-00991">38</xref>].</p></sec></sec><sec sec-type="results"><title>3. Results and Discussion</title><sec><title>3.1. The Interaction Surfaces of the Rhodocytin-CLEC-2 Interaction</title><p>There are two alpha and two beta subunits of rhodocytin per tetrameric unit. The most basic model of the interaction of rhodocytin with CLEC-2 is that in which one molecule of dimeric CLEC-2 is complexed with one molecule of rhodocytin, the rhodocytin being in the form of the non-disulfide linked (αβ)<sub>2</sub> tetramer that was identified by crystallography [<xref ref-type="bibr" rid="B33-toxins-03-00991">33</xref>]. In this complex, there are two hydrogen bonds and one salt bridge involved in the interaction between dimeric CLEC-2 and one beta subunit of rhodocytin (<xref ref-type="table" rid="toxins-03-00991-t001">Table 1</xref>). However, in this model, the other beta subunit of the tetramer does not bind to the CLEC-2 dimer (<xref ref-type="table" rid="toxins-03-00991-t001">Table 1</xref>). In addition to the interactions with the beta subunit of rhodocytin, dimeric CLEC-2 interacts with one alpha subunit of rhodocytin through five hydrogen bonds and three salt bridges (<xref ref-type="table" rid="toxins-03-00991-t001">Table 1</xref>). In contrast to the beta subunits, where only one interacts with CLEC-2, this second alpha subunit does interact with the CLEC-2 dimer in this model, but does not form any ionic bonds with it (<xref ref-type="table" rid="toxins-03-00991-t001">Table 1</xref>). It is likely that this interaction with the second alpha subunit is mediated by van der Waals forces.</p><p>The more complex model of the rhodocytin-CLEC-2 interaction involves two copies of dimeric CLEC-2 bound to one molecule of the non-disulfide linked (αβ)<sub>2</sub> tetrameric form of rhodocytin. It is important to note that this model is distinct from that described above, and has been generated independently in a way that has not been influenced by the first model. In this complex, four hydrogen bonds and one salt bridge are involved in the interaction between each molecule of dimeric CLEC-2 and each rhodocytin beta subunit (<xref ref-type="table" rid="toxins-03-00991-t002">Table 2</xref>). In addition, the interaction between each alpha subunit of rhodocytin and each molecule of dimeric CLEC-2 involves a further two hydrogen bonds and one salt bridge (<xref ref-type="table" rid="toxins-03-00991-t002">Table 2</xref>). Clearly, this model in which two CLEC-2 dimers associate with tetrameric rhodocytin involves more numerous and favourable ionic interactions and hydrogen bonds (a total of sixteen, as opposed to eleven interactions per tetramer of rhodocytin) in addition to van der Waals contacts and would therefore be a more likely model (<xref ref-type="fig" rid="toxins-03-00991-f001">Figure 1</xref>). Interestingly, residue K150 of CLEC-2, which we identified as being important for its interaction with rhodocytin using mutagenesis and surface plasmon resonance, is also involved in the interface in this model of the complex [<xref ref-type="bibr" rid="B30-toxins-03-00991">30</xref>].</p><p>There are 246 bound water molecules present in the crystal structure of monomeric CLEC-2 and 45 water molecules present in the crystal structure of rhodocytin. Therefore, upon dimerization of CLEC-2 and complexing of this dimeric CLEC-2 with tetrameric rhodocytin, there will be considerable liberation of the water molecules which solvate the unbound molecules. In our model where one copy of dimeric CLEC-2 binds tetrameric rhodocytin, the alpha subunits and the one beta subunit involved in the complex experience gains in the free energy of solvation of 1.5, 2.5 and 0.2 kcal/mol respectively (total 4.2 kcal/mol). However, in our more complex model in which two CLEC-2 dimers bind to one tetramer of rhodocytin, the solvation energy gains for each CLEC-2 dimer interaction are 0.2 and 0.6 kcal/mol for the alpha subunits, and 2.2 and 0.7 kcal for the two beta subunits (total 7.4 kcal/mol). There is, therefore, a more appreciable gain in the free energy of solvation upon formation of the complex of two CLEC-2 dimers rather than one with tetrameric rhodocytin, which again indicates that this is a more plausible model.</p><table-wrap id="toxins-03-00991-t001" position="anchor"><object-id pub-id-type="pii">toxins-03-00991-t001_Table 1</object-id><label>Table 1</label><caption><p>Contact information and interfacing residues involved in the model interaction of one copy of dimeric CLEC-2 with tetrameric rhodocytin. Key: H = residues making hydrogen bonds, S = residues making a salt bridge, ASA = accessible surface area (Ų), BSA = buried surface area (Ų), ΔiG = solvation energy effect (kcal/mol), |||| = buried area percentage, one bar per 10%.</p></caption><table frame="hsides" rules="groups"><tbody><tr><td rowspan="1" colspan="1"><inline-graphic xlink:href="toxins-03-00991-i001.jpg"></inline-graphic></td></tr></tbody></table></table-wrap><table-wrap id="toxins-03-00991-t002" position="anchor"><object-id pub-id-type="pii">toxins-03-00991-t002_Table 2</object-id><label>Table 2</label><caption><p>Contact information and interfacing residues involved in the model interaction of two copies of dimeric CLEC-2 with tetrameric rhodocytin. Key: H = residues making hydrogen bonds, S = residues making a salt bridge, ASA = accessible surface area (Ų), BSA = buried surface area (Ų), ΔiG = solvation energy effect (kcal/mol), |||| = buried area percentage, one bar per 10 %.</p></caption><table frame="hsides" rules="groups"><tbody><tr><td rowspan="1" colspan="1"><inline-graphic xlink:href="toxins-03-00991-i002.jpg"></inline-graphic></td></tr></tbody></table></table-wrap><fig id="toxins-03-00991-f001" position="anchor"><label>Figure 1</label><caption><p>Representation of an interface between CLEC-2 (white) and a beta subunit (pink) of the rhodocytin tetramer. Sidechains of interacting residues (N120 and K211 on CLEC-2, and E95 and D110 on the beta subunit of rhodocytin) are represented as balls and sticks. Predicted hydrogen bonds are represented by broken dotted blue lines.</p></caption><graphic xlink:href="toxins-03-00991-g001"></graphic></fig></sec><sec><title>3.2. Dynamic Flexibility of the Rhodocytin-CLEC-2 Complexes</title><p>Molecular dynamics analyses were undertaken to investigate the potential flexibility of the two possible rhodocytin-CLEC-2 interaction models (<xref ref-type="fig" rid="toxins-03-00991-f002">Figure 2</xref>, <xref ref-type="fig" rid="toxins-03-00991-f003">Figure 3</xref>). With only a single dimer of CLEC-2 interacting with tetrameric rhodocytin, the predicted motions are dominated by the alpha and beta subunits of rhodocytin and the motions of CLEC-2 appear to play a relatively minor part in the overall flexibility of the complex (<xref ref-type="fig" rid="toxins-03-00991-f002">Figure 2</xref>). Interestingly, in the model with two copies of dimeric CLEC-2 bound to rhodocytin, a much greater contribution is made by the CLEC-2 dimers, and the beta subunits of rhodocytin, to the global flexibility of the complex (<xref ref-type="fig" rid="toxins-03-00991-f003">Figure 3</xref>). In the molecular dynamics simulations for this model, the CLEC-2 dimers appear to wrap around the grooves presented on rhodocytin, and the beta subunits move in a complementary fashion so as to maximise the exposure and accessibility of the two binding grooves to CLEC-2 (<xref ref-type="fig" rid="toxins-03-00991-f003">Figure 3</xref>). Thus, in this interaction mode with two CLEC-2 molecules, the alpha subunits of rhodocytin make a relatively more minor contribution to the possible dynamic motions of the complex (<xref ref-type="fig" rid="toxins-03-00991-f003">Figure 3</xref>).</p><fig id="toxins-03-00991-f002" position="anchor"><label>Figure 2</label><caption><p>Dynamic analyses of a model of the interaction of dimeric CLEC-2 (white) with tetrameric rhodocytin. The rhodocytin α- and β-chains are coloured yellow and pink, respectively. The porcupine plots represent the principal mode of conformational variability of the Cα atoms calculated from a CONCOORD ensemble using the model of the rhodocytin-CLEC-2 interaction based on the crystal structure of rhodocytin, and a model of the dimeric structure of CLEC-2. Blue cones represent the direction of each motion; the length of the cone is proportional to the amplitude of the motion. The top image represents a 90° counter-clockwise rotation of the central image about the X-axis. The bottom image represents a 90° clockwise rotation of the top image about the Y-axis.</p></caption><graphic xlink:href="toxins-03-00991-g002"></graphic></fig><fig id="toxins-03-00991-f003" position="anchor"><label>Figure 3</label><caption><p>Dynamic analyses of a model of the interaction of two copies of dimeric CLEC-2 (white) with tetrameric rhodocytin. The rhodocytin α- and β-chains are coloured yellow and pink, respectively. The porcupine plots represent the principal mode of conformational variability of the Cα atoms calculated from a CONCOORD ensemble using the model of the rhodocytin-CLEC-2 interaction based on the crystal structure of rhodocytin, and a model of the dimeric structure of CLEC-2. Blue cones represent the direction of each motion; the length of the cone is proportional to the amplitude of the motion. The top image represents a 90° counter-clockwise rotation of the central image about the X-axis. The bottom image represents a 90° clockwise rotation of the top image about the Y-axis.</p></caption><graphic xlink:href="toxins-03-00991-g003"></graphic></fig></sec></sec><sec sec-type="conclusions"><title>4. Conclusions</title><p>We have previously solved the crystal structures of both rhodocytin and CLEC-2, but there is no crystallographic structure of the rhodocytin-CLEC-2 complex. Using three dimensional structures of both rhodocytin and CLEC-2, we have generated models of the likely modes of interaction of the venom protein and its receptor on platelets and have investigated and analysed the computational models of the interaction which we have generated [<xref ref-type="bibr" rid="B30-toxins-03-00991">30</xref>,<xref ref-type="bibr" rid="B32-toxins-03-00991">32</xref>,<xref ref-type="bibr" rid="B33-toxins-03-00991">33</xref>]. Using a set of analytical algorithms and approaches, we have assessed the properties of the interfacing surfaces and the contribution made to the interaction by specific intermolecular contacts, including salt bridges and hydrogen bonds. In addition to this, we have evaluated the potential flexibility of these model complexes. The model wherein two molecules of CLEC-2 associate with tetrameric rhodocytin provides a more plausible model in terms of the composite effects related to the number of interfacing residues, the nature of their interactions and the predicted solvation energy effects. Further, it is of potential significance that the predicted dynamic motions of this complex are suggestive of a mechanism whereby this interaction might cluster the receptors on the platelet surface, which could have implications for signaling. Overall, the work presented indicates that a plausible mode of binding is that of one non-disulfide linked (αβ)<sub>2</sub> tetramer of rhodocytin with two dimers of CLEC-2. This analysis will be of value in the development of further studies to characterise the interaction further with a view to developing therapeutic approaches to disrupt the rhodocytin-CLEC-2 interaction on the platelet surface.</p></sec></body><back><ack><title>Acknowledgments</title><p>This work was funded by the British Heart Foundation. AAW is a Sir Henry Wellcome Postdoctoral Fellow. We are grateful to Steve Watson for helpful discussions. </p></ack><notes><title>Conflict of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-toxins-03-00991"><label>1.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Pirkle</surname><given-names>H.</given-names></name><name><surname>Markland</surname><given-names>F.S.</given-names><suffix>Jr.</suffix></name></person-group><source>Hemostasis and Animal Venoms</source><publisher-name>Dekker</publisher-name><publisher-loc>New York, NY, USA</publisher-loc><year>1987</year></element-citation></ref><ref id="B2-toxins-03-00991"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clemetson</surname><given-names>K.J.</given-names></name><name><surname>Lu</surname><given-names>Q.</given-names></name><name><surname>Clemetson</surname><given-names>J.M.</given-names></name></person-group><article-title>Snake venom proteins affecting platelets and their applications to anti-thrombotic research</article-title><source>Curr. Pharm. Des.</source><year>2007</year><volume>13</volume><fpage>2887</fpage><lpage>2892</lpage><pub-id pub-id-type="pmid">17979733</pub-id></element-citation></ref><ref id="B3-toxins-03-00991"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clemetson</surname><given-names>K.J.</given-names></name><name><surname>Lu</surname><given-names>Q.</given-names></name><name><surname>Clemetson</surname><given-names>J.M.</given-names></name></person-group><article-title>Snake C-type lectin-like proteins and platelet receptors</article-title><source>Pathophysiol. Haemost. Thromb.</source><year>2005</year><volume>34</volume><fpage>150</fpage><lpage>155</lpage><pub-id pub-id-type="pmid">16707918</pub-id></element-citation></ref><ref id="B4-toxins-03-00991"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruggeri</surname><given-names>Z.M.</given-names></name></person-group><article-title>Platelets in atherothrombosis</article-title><source>Nat. Med.</source><year>2002</year><volume>8</volume><fpage>1227</fpage><lpage>1234</lpage><pub-id pub-id-type="pmid">12411949</pub-id></element-citation></ref><ref id="B5-toxins-03-00991"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lusis</surname><given-names>A.J.</given-names></name></person-group><article-title>Atherosclerosis</article-title><source>Nature</source><year>2000</year><volume>407</volume><fpage>233</fpage><lpage>241</lpage><pub-id pub-id-type="pmid">11001066</pub-id></element-citation></ref><ref id="B6-toxins-03-00991"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname><given-names>M.</given-names></name><name><surname>Warrell</surname><given-names>D.A.</given-names></name><name><surname>Looareesuwan</surname><given-names>S.</given-names></name><name><surname>Phillips</surname><given-names>R.E.</given-names></name><name><surname>Chanthavanich</surname><given-names>P.</given-names></name><name><surname>Karbwang</surname><given-names>J.</given-names></name><name><surname>Supanaranond</surname><given-names>W.</given-names></name><name><surname>Viravan</surname><given-names>C.</given-names></name><name><surname>Hutton</surname><given-names>R.A.</given-names></name><name><surname>Vejcho</surname><given-names>S.</given-names></name></person-group><article-title>Clinical significance of venom antigen levels in patients envenomed by the malayan pit viper (<italic>Calloselasma rhodostoma</italic>)</article-title><source>Am. J. Trop. Med. Hyg.</source><year>1986</year><volume>35</volume><fpage>579</fpage><lpage>587</lpage><pub-id pub-id-type="pmid">3706625</pub-id></element-citation></ref><ref id="B7-toxins-03-00991"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>T.F.</given-names></name><name><surname>Liu</surname><given-names>C.Z.</given-names></name><name><surname>Yang</surname><given-names>S.H.</given-names></name></person-group><article-title>Aggretin, a novel platelet-aggregation inducer from snake (Calloselasma rhodostoma) venom, activates phospholipase c by acting as a glycoprotein ia/iia agonist</article-title><source>Biochem. J.</source><year>1995</year><volume>309</volume><fpage>1021</fpage><lpage>1027</lpage><pub-id pub-id-type="pmid">7639679</pub-id></element-citation></ref><ref id="B8-toxins-03-00991"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>Y.</given-names></name><name><surname>Morita</surname><given-names>T.</given-names></name></person-group><article-title>Rhodocytin, a functional novel platelet agonist belonging to the heterodimeric c-type lectin family, induces platelet aggregation independently of glycoprotein ib</article-title><source>Biochem. Biophys. Res. Commun.</source><year>1998</year><volume>245</volume><fpage>741</fpage><lpage>745</lpage><pub-id pub-id-type="pmid">9588185</pub-id><pub-id pub-id-type="doi">10.1006/bbrc.1998.8516</pub-id></element-citation></ref><ref id="B9-toxins-03-00991"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname><given-names>C.H.</given-names></name><name><surname>Au</surname><given-names>L.C.</given-names></name><name><surname>Huang</surname><given-names>T.F.</given-names></name></person-group><article-title>Molecular cloning and sequence analysis of aggretin, a collagen-like platelet aggregation inducer</article-title><source>Biochem. Biophys. Res. Commun.</source><year>1999</year><volume>263</volume><fpage>723</fpage><lpage>727</lpage><pub-id pub-id-type="pmid">10512747</pub-id></element-citation></ref><ref id="B10-toxins-03-00991"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suzuki-Inoue</surname><given-names>K.</given-names></name><name><surname>Fuller</surname><given-names>G.L.</given-names></name><name><surname>Garcia</surname><given-names>A.</given-names></name><name><surname>Eble</surname><given-names>J.A.</given-names></name><name><surname>Pohlmann</surname><given-names>S.</given-names></name><name><surname>Inoue</surname><given-names>O.</given-names></name><name><surname>Gartner</surname><given-names>T.K.</given-names></name><name><surname>Hughan</surname><given-names>S.C.</given-names></name><name><surname>Pearce</surname><given-names>A.C.</given-names></name><name><surname>Laing</surname><given-names>G.D.</given-names></name><etal></etal></person-group><article-title>A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2</article-title><source>Blood</source><year>2006</year><volume>107</volume><fpage>542</fpage><lpage>549</lpage><pub-id pub-id-type="pmid">16174766</pub-id></element-citation></ref><ref id="B11-toxins-03-00991"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuller</surname><given-names>G.L.</given-names></name><name><surname>Williams</surname><given-names>J.A.</given-names></name><name><surname>Tomlinson</surname><given-names>M.G.</given-names></name><name><surname>Eble</surname><given-names>J.A.</given-names></name><name><surname>Hanna</surname><given-names>S.L.</given-names></name><name><surname>Pohlmann</surname><given-names>S.</given-names></name><name><surname>Suzuki-Inoue</surname><given-names>K.</given-names></name><name><surname>Ozaki</surname><given-names>Y.</given-names></name><name><surname>Watson</surname><given-names>S.P.</given-names></name><name><surname>Pearce</surname><given-names>A.C.</given-names></name></person-group><article-title>The C-type lectin receptors CLEC-2 and Dectin-1, but not DC-SIGN, signal via a novel YXXL-dependent signaling cascade</article-title><source>J. Biol. Chem.</source><year>2007</year><volume>282</volume><fpage>12397</fpage><lpage>12409</lpage><pub-id pub-id-type="pmid">17339324</pub-id></element-citation></ref><ref id="B12-toxins-03-00991"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Callaghan</surname><given-names>C.A.</given-names></name></person-group><article-title>Thrombomodulation via CLEC-2 targeting</article-title><source>Curr. Opin. Pharmacol.</source><year>2009</year><volume>9</volume><fpage>90</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">19091630</pub-id></element-citation></ref><ref id="B13-toxins-03-00991"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Callaghan</surname><given-names>C.A.</given-names></name><name><surname>Tormo</surname><given-names>J.</given-names></name><name><surname>Willcox</surname><given-names>B.E.</given-names></name><name><surname>Braud</surname><given-names>V.M.</given-names></name><name><surname>Jakobsen</surname><given-names>B.K.</given-names></name><name><surname>Stuart</surname><given-names>D.I.</given-names></name><name><surname>McMichael</surname><given-names>A.J.</given-names></name><name><surname>Bell</surname><given-names>J.I.</given-names></name><name><surname>Jones</surname><given-names>E.Y.</given-names></name></person-group><article-title>Structural features impose tight peptide binding specificity in the non-classical MHC molecule HLA-E</article-title><source>Mol. Cell</source><year>1998</year><volume>1</volume><fpage>531</fpage><lpage>541</lpage><pub-id pub-id-type="pmid">9660937</pub-id></element-citation></ref><ref id="B14-toxins-03-00991"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braud</surname><given-names>V.</given-names></name><name><surname>Allan</surname><given-names>D.S.J.</given-names></name><name><surname>O’Callaghan</surname><given-names>C.A.</given-names></name><name><surname>Ogg</surname><given-names>G.S.</given-names></name><name><surname>Lazetic</surname><given-names>S.</given-names></name><name><surname>Young</surname><given-names>N.T.</given-names></name><name><surname>Bell</surname><given-names>J.I.</given-names></name><name><surname>Phillips</surname><given-names>J.H.</given-names></name><name><surname>Lanier</surname><given-names>L.L.</given-names></name><name><surname>McMichael</surname><given-names>A.J.</given-names></name></person-group><article-title>HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C</article-title><source>Nature</source><year>1998</year><volume>391</volume><fpage>795</fpage><lpage>799</lpage><pub-id pub-id-type="pmid">9486650</pub-id></element-citation></ref><ref id="B15-toxins-03-00991"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Callaghan</surname><given-names>C.A.</given-names></name><name><surname>Cerwenka</surname><given-names>A.</given-names></name><name><surname>Willcox</surname><given-names>B.E.</given-names></name><name><surname>Lanier</surname><given-names>L.L.</given-names></name><name><surname>Bjorkman</surname><given-names>P.J.</given-names></name></person-group><article-title>Molecular competition for NKG2D: H60 and RAE1 compete unequally for NKG2D with dominance of H60</article-title><source>Immunity</source><year>2001</year><volume>15</volume><fpage>201</fpage><lpage>211</lpage><pub-id pub-id-type="pmid">11520456</pub-id></element-citation></ref><ref id="B16-toxins-03-00991"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christou</surname><given-names>C.M.</given-names></name><name><surname>Pearce</surname><given-names>A.C.</given-names></name><name><surname>Watson</surname><given-names>A.A.</given-names></name><name><surname>Mistry</surname><given-names>A.R.</given-names></name><name><surname>Pollitt</surname><given-names>A.Y.</given-names></name><name><surname>Fenton-May</surname><given-names>A.E.</given-names></name><name><surname>Johnson</surname><given-names>L.A.</given-names></name><name><surname>Jackson</surname><given-names>D.G.</given-names></name><name><surname>Watson</surname><given-names>S.P.</given-names></name><name><surname>O’Callaghan</surname><given-names>C.A.</given-names></name></person-group><article-title>Renal cells activate the platelet receptor CLEC-2 through podoplanin</article-title><source>Biochem. J.</source><year>2008</year><volume>411</volume><fpage>133</fpage><lpage>140</lpage><pub-id pub-id-type="pmid">18215137</pub-id></element-citation></ref><ref id="B17-toxins-03-00991"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Callaghan</surname><given-names>C.A.</given-names></name><name><surname>Jones</surname><given-names>E.Y.</given-names></name></person-group><article-title>Structural and energetic aspects of multispecific immune recognition by NKG2D</article-title><source>Structure (Camb.)</source><year>2003</year><volume>11</volume><fpage>360</fpage><lpage>361</lpage><pub-id pub-id-type="doi">10.1016/S0969-2126(03)00055-8</pub-id><pub-id pub-id-type="pmid">12679010</pub-id></element-citation></ref><ref id="B18-toxins-03-00991"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cueni</surname><given-names>L.N.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Marino</surname><given-names>D.</given-names></name><name><surname>Huggenberger</surname><given-names>R.</given-names></name><name><surname>Alitalo</surname><given-names>A.</given-names></name><name><surname>Bianchi</surname><given-names>R.</given-names></name><name><surname>Detmar</surname><given-names>M.</given-names></name></person-group><article-title>Podoplanin-fc reduces lymphatic vessel formation <italic>in vitro</italic> and <italic>in vivo</italic> and causes disseminated intravascular coagulation when transgenically expressed in the skin</article-title><source>Blood</source><year>2010</year><volume>116</volume><fpage>4376</fpage><lpage>4384</lpage><pub-id pub-id-type="pmid">20716773</pub-id><pub-id pub-id-type="doi">10.1182/blood-2010-04-278564</pub-id></element-citation></ref><ref id="B19-toxins-03-00991"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suzuki-Inoue</surname><given-names>K.</given-names></name><name><surname>Kato</surname><given-names>Y.</given-names></name><name><surname>Inoue</surname><given-names>O.</given-names></name><name><surname>Kaneko</surname><given-names>M.K.</given-names></name><name><surname>Mishima</surname><given-names>K.</given-names></name><name><surname>Yatomi</surname><given-names>Y.</given-names></name><name><surname>Narimatsu</surname><given-names>H.</given-names></name><name><surname>Ozaki</surname><given-names>Y.</given-names></name></person-group><article-title>Involvement of the snake toxin receptor CLEC-2 in podoplanin-mediated platelet activation by cancer cells</article-title><source>J.Biol.Chem.</source><year>2007</year><volume>282</volume><fpage>25993</fpage><lpage>26001</lpage><pub-id pub-id-type="pmid">17616532</pub-id></element-citation></ref><ref id="B20-toxins-03-00991"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin-Villar</surname><given-names>E.</given-names></name><name><surname>Scholl</surname><given-names>F.G.</given-names></name><name><surname>Gamallo</surname><given-names>C.</given-names></name><name><surname>Yurrita</surname><given-names>M.M.</given-names></name><name><surname>Munoz-Guerra</surname><given-names>M.</given-names></name><name><surname>Cruces</surname><given-names>J.</given-names></name><name><surname>Quintanilla</surname><given-names>M.</given-names></name></person-group><article-title>Characterization of human pa2.26 antigen (t1alpha-2, podoplanin), a small membrane mucin induced in oral squamous cell carcinomas</article-title><source>Int. J. Cancer</source><year>2005</year><volume>113</volume><fpage>899</fpage><lpage>910</lpage><pub-id pub-id-type="pmid">15515019</pub-id><pub-id pub-id-type="doi">10.1002/ijc.20656</pub-id></element-citation></ref><ref id="B21-toxins-03-00991"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uhrin</surname><given-names>P.</given-names></name><name><surname>Zaujec</surname><given-names>J.</given-names></name><name><surname>Breuss</surname><given-names>J.M.</given-names></name><name><surname>Olcaydu</surname><given-names>D.</given-names></name><name><surname>Chrenek</surname><given-names>P.</given-names></name><name><surname>Stockinger</surname><given-names>H.</given-names></name><name><surname>Fuertbauer</surname><given-names>E.</given-names></name><name><surname>Moser</surname><given-names>M.</given-names></name><name><surname>Haiko</surname><given-names>P.</given-names></name><name><surname>Fassler</surname><given-names>R.</given-names></name><etal></etal></person-group><article-title>Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation</article-title><source>Blood</source><year>2010</year><volume>115</volume><fpage>3997</fpage><lpage>4005</lpage><pub-id pub-id-type="pmid">20110424</pub-id><pub-id pub-id-type="doi">10.1182/blood-2009-04-216069</pub-id></element-citation></ref><ref id="B22-toxins-03-00991"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schacht</surname><given-names>V.</given-names></name><name><surname>Ramirez</surname><given-names>M.I.</given-names></name><name><surname>Hong</surname><given-names>Y.K.</given-names></name><name><surname>Hirakawa</surname><given-names>S.</given-names></name><name><surname>Feng</surname><given-names>D.</given-names></name><name><surname>Harvey</surname><given-names>N.</given-names></name><name><surname>Williams</surname><given-names>M.</given-names></name><name><surname>Dvorak</surname><given-names>A.M.</given-names></name><name><surname>Dvorak</surname><given-names>H.F.</given-names></name><name><surname>Oliver</surname><given-names>G.</given-names></name><etal></etal></person-group><article-title>T1alpha/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema</article-title><source>EMBO J.</source><year>2003</year><volume>22</volume><fpage>3546</fpage><lpage>3556</lpage><pub-id pub-id-type="doi">10.1093/emboj/cdg342</pub-id><pub-id pub-id-type="pmid">12853470</pub-id></element-citation></ref><ref id="B23-toxins-03-00991"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahtab</surname><given-names>E.A.</given-names></name><name><surname>Vicente-Steijn</surname><given-names>R.</given-names></name><name><surname>Hahurij</surname><given-names>N.D.</given-names></name><name><surname>Jongbloed</surname><given-names>M.R.</given-names></name><name><surname>Wisse</surname><given-names>L.J.</given-names></name><name><surname>DeRuiter</surname><given-names>M.C.</given-names></name><name><surname>Uhrin</surname><given-names>P.</given-names></name><name><surname>Zaujec</surname><given-names>J.</given-names></name><name><surname>Binder</surname><given-names>B.R.</given-names></name><name><surname>Schalij</surname><given-names>M.J.</given-names></name><etal></etal></person-group><article-title>Podoplanin deficient mice show a rhoa-related hypoplasia of the sinus venosus myocardium including the sinoatrial node</article-title><source>Dev. Dyn.</source><year>2009</year><volume>238</volume><fpage>183</fpage><lpage>193</lpage><pub-id pub-id-type="pmid">19097191</pub-id></element-citation></ref><ref id="B24-toxins-03-00991"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Douglas</surname><given-names>Y.L.</given-names></name><name><surname>Mahtab</surname><given-names>E.A.</given-names></name><name><surname>Jongbloed</surname><given-names>M.R.</given-names></name><name><surname>Uhrin</surname><given-names>P.</given-names></name><name><surname>Zaujec</surname><given-names>J.</given-names></name><name><surname>Binder</surname><given-names>B.R.</given-names></name><name><surname>Schalij</surname><given-names>M.J.</given-names></name><name><surname>Poelmann</surname><given-names>R.E.</given-names></name><name><surname>Deruiter</surname><given-names>M.C.</given-names></name><name><surname>Gittenberger-de Groot</surname><given-names>A.C.</given-names></name></person-group><article-title>Pulmonary vein, dorsal atrial wall and atrial septum abnormalities in podoplanin knockout mice with disturbed posterior heart field contribution</article-title><source>Pediatr. Res.</source><year>2009</year><volume>65</volume><fpage>27</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">18784615</pub-id></element-citation></ref><ref id="B25-toxins-03-00991"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hughes</surname><given-names>C.E.</given-names></name><name><surname>Navarro-Núñez</surname><given-names>L.</given-names></name><name><surname>Finney</surname><given-names>B.A.</given-names></name><name><surname>Mourão-Sá</surname><given-names>D.</given-names></name><name><surname>Pollitt</surname><given-names>A.Y.</given-names></name><name><surname>Watson</surname><given-names>S.P.</given-names></name></person-group><article-title>CLEC-2 is not required for platelet aggregation at arteriolar shear</article-title><source>J. Thromb. Haemost.</source><year>2010</year><volume>8</volume><fpage>2328</fpage><lpage>2332</lpage><pub-id pub-id-type="pmid">20695981</pub-id></element-citation></ref><ref id="B26-toxins-03-00991"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>T.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Tang</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Lin</surname><given-names>W.Y.</given-names></name><name><surname>Martin</surname><given-names>F.</given-names></name><name><surname>Grant</surname><given-names>D.</given-names></name><name><surname>Solloway</surname><given-names>M.</given-names></name><name><surname>Parker</surname><given-names>L.</given-names></name><name><surname>Ye</surname><given-names>W.</given-names></name><etal></etal></person-group><article-title>A mouse knockout library for secreted and transmembrane proteins</article-title><source>Nat. Biotechnol.</source><year>2010</year><volume>28</volume><fpage>749</fpage><lpage>755</lpage><pub-id pub-id-type="pmid">20562862</pub-id></element-citation></ref><ref id="B27-toxins-03-00991"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bertozzi</surname><given-names>C.C.</given-names></name><name><surname>Schmaier</surname><given-names>A.A.</given-names></name><name><surname>Mericko</surname><given-names>P.</given-names></name><name><surname>Hess</surname><given-names>P.R.</given-names></name><name><surname>Zou</surname><given-names>Z.</given-names></name><name><surname>Chen</surname><given-names>M.</given-names></name><name><surname>Chen</surname><given-names>C.Y.</given-names></name><name><surname>Xu</surname><given-names>B.</given-names></name><name><surname>Lu</surname><given-names>M.M.</given-names></name><name><surname>Zhou</surname><given-names>D.</given-names></name><etal></etal></person-group><article-title>Platelets regulate lymphatic vascular development through CLEC-2-SLP-76 signaling</article-title><source>Blood</source><year>2010</year><volume>116</volume><fpage>661</fpage><lpage>670</lpage><pub-id pub-id-type="pmid">20363774</pub-id><pub-id pub-id-type="doi">10.1182/blood-2010-02-270876</pub-id></element-citation></ref><ref id="B28-toxins-03-00991"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suzuki-Inoue</surname><given-names>K.</given-names></name><name><surname>Inoue</surname><given-names>O.</given-names></name><name><surname>Ding</surname><given-names>G.</given-names></name><name><surname>Nishimura</surname><given-names>S.</given-names></name><name><surname>Hokamura</surname><given-names>K.</given-names></name><name><surname>Eto</surname><given-names>K.</given-names></name><name><surname>Kashiwagi</surname><given-names>H.</given-names></name><name><surname>Tomiyama</surname><given-names>Y.</given-names></name><name><surname>Yatomi</surname><given-names>Y.</given-names></name><name><surname>Umemura</surname><given-names>K.</given-names></name><etal></etal></person-group><article-title>Essential <italic>in vivo</italic> roles of the C-type lectin receptor CLEC-2: Embryonic/neonatal lethality of CLEC-2-deficient mice by blood/lymphatic misconnections and impaired thrombus formation of CLEC-2-deficient platelets</article-title><source>J. Biol. Chem.</source><year>2010</year><volume>285</volume><fpage>24494</fpage><lpage>24507</lpage><pub-id pub-id-type="pmid">20525685</pub-id></element-citation></ref><ref id="B29-toxins-03-00991"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chippaux</surname><given-names>J.P.</given-names></name></person-group><article-title>Snake-bites: Appraisal of the global situation</article-title><source>Bull. WHO</source><year>1998</year><volume>76</volume><fpage>515</fpage><lpage>524</lpage><pub-id pub-id-type="pmid">9868843</pub-id></element-citation></ref><ref id="B30-toxins-03-00991"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watson</surname><given-names>A.A.</given-names></name><name><surname>Brown</surname><given-names>J.</given-names></name><name><surname>Harlos</surname><given-names>K.</given-names></name><name><surname>Eble</surname><given-names>J.A.</given-names></name><name><surname>Walter</surname><given-names>T.S.</given-names></name><name><surname>O’Callaghan</surname><given-names>C.A.</given-names></name></person-group><article-title>The crystal structure and mutational binding analysis of the extracellular domain of the platelet-activating receptor CLEC-2</article-title><source>J. Biol. Chem.</source><year>2007</year><volume>282</volume><fpage>3165</fpage><lpage>3172</lpage><pub-id pub-id-type="pmid">17132623</pub-id></element-citation></ref><ref id="B31-toxins-03-00991"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watson</surname><given-names>A.A.</given-names></name><name><surname>O’Callaghan</surname><given-names>C.A.</given-names></name></person-group><article-title>Crystallization and X-ray diffraction analysis of human CLEC-2</article-title><source>Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun.</source><year>2005</year><volume>61</volume><fpage>1094</fpage><lpage>1096</lpage></element-citation></ref><ref id="B32-toxins-03-00991"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watson</surname><given-names>A.A.</given-names></name><name><surname>Christou</surname><given-names>C.M.</given-names></name><name><surname>James</surname><given-names>J.R.</given-names></name><name><surname>Fenton-May</surname><given-names>A.E.</given-names></name><name><surname>Moncayo</surname><given-names>G.E.</given-names></name><name><surname>Mistry</surname><given-names>A.R.</given-names></name><name><surname>Davis</surname><given-names>S.J.</given-names></name><name><surname>Gilbert</surname><given-names>R.J.</given-names></name><name><surname>Chakera</surname><given-names>A.</given-names></name><name><surname>O’Callaghan</surname><given-names>C.A.</given-names></name></person-group><article-title>The platelet receptor CLEC-2 is active as a dimer</article-title><source>Biochemistry</source><year>2009</year><volume>48</volume><fpage>10988</fpage><lpage>10996</lpage><pub-id pub-id-type="pmid">19824697</pub-id></element-citation></ref><ref id="B33-toxins-03-00991"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watson</surname><given-names>A.A.</given-names></name><name><surname>Eble</surname><given-names>J.A.</given-names></name><name><surname>O’Callaghan</surname><given-names>C.A.</given-names></name></person-group><article-title>Crystal structure of rhodocytin, a ligand for the platelet-activating receptor CLEC-2</article-title><source>Protein Sci.</source><year>2008</year><volume>17</volume><fpage>1611</fpage><lpage>1616</lpage><pub-id pub-id-type="pmid">18583525</pub-id></element-citation></ref><ref id="B34-toxins-03-00991"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hughes</surname><given-names>C.E.</given-names></name><name><surname>Pollitt</surname><given-names>A.Y.</given-names></name><name><surname>Mori</surname><given-names>J.</given-names></name><name><surname>Eble</surname><given-names>J.A.</given-names></name><name><surname>Tomlinson</surname><given-names>M.G.</given-names></name><name><surname>Hartwig</surname><given-names>J.H.</given-names></name><name><surname>O’Callaghan</surname><given-names>C.A.</given-names></name><name><surname>Futterer</surname><given-names>K.</given-names></name><name><surname>Watson</surname><given-names>S.P.</given-names></name></person-group><article-title>CLEC-2 activates Syk through dimerization</article-title><source>Blood</source><year>2010</year><volume>115</volume><fpage>2947</fpage><lpage>2955</lpage><pub-id pub-id-type="pmid">20154219</pub-id></element-citation></ref><ref id="B35-toxins-03-00991"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krissinel</surname><given-names>E.</given-names></name><name><surname>Henrick</surname><given-names>K.</given-names></name></person-group><article-title>Inference of macromolecular assemblies from crystalline state</article-title><source>J. Mol.Biol.</source><year>2007</year><volume>372</volume><fpage>774</fpage><lpage>797</lpage><pub-id pub-id-type="pmid">17681537</pub-id></element-citation></ref><ref id="B36-toxins-03-00991"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barrett</surname><given-names>C.P.</given-names></name><name><surname>Hall</surname><given-names>B.A.</given-names></name><name><surname>Noble</surname><given-names>M.E.</given-names></name></person-group><article-title>Dynamite: A simple way to gain insight into protein motions</article-title><source>Acta Crystallogr. D Biol. Crystallogr.</source><year>2004</year><volume>60</volume><fpage>2280</fpage><lpage>2287</lpage><pub-id pub-id-type="pmid">15572782</pub-id></element-citation></ref><ref id="B37-toxins-03-00991"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Groot</surname><given-names>B.L.</given-names></name><name><surname>van Aalten</surname><given-names>D.M.</given-names></name><name><surname>Scheek</surname><given-names>R.M.</given-names></name><name><surname>Amadei</surname><given-names>A.</given-names></name><name><surname>Vriend</surname><given-names>G.</given-names></name><name><surname>Berendsen</surname><given-names>H.J.</given-names></name></person-group><article-title>Prediction of protein conformational freedom from distance constraints</article-title><source>Proteins</source><year>1997</year><volume>29</volume><fpage>240</fpage><lpage>251</lpage><pub-id pub-id-type="pmid">9329088</pub-id></element-citation></ref><ref id="B38-toxins-03-00991"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Humphrey</surname><given-names>W.</given-names></name><name><surname>Dalke</surname><given-names>A.</given-names></name><name><surname>Schulten</surname><given-names>K.</given-names></name></person-group><article-title>VMD: Visual molecular dynamics</article-title><source>J. Mol. Graph.</source><year>1996</year><volume>14</volume><fpage>33</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">8744570</pub-id><pub-id pub-id-type="doi">10.1016/0263-7855(96)00018-5</pub-id></element-citation></ref></ref-list></back></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004650 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 004650 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Pmc
|étape= Corpus
|type= RBID
|clé=
|texte=
}}
| This area was generated with Dilib version V0.6.31. |  |